期刊文献+

非小细胞肺癌中VEGF-C、CD44v6的表达及临床意义 被引量:3

Clinical significance of vascular endothelial growth factor C and CD44v6 expressions in human non-small cell lung cancer
原文传递
导出
摘要 目的研究血管内皮生长因子-C(VEGF-C)和细胞粘附因子(CD44v6)在非小细胞肺癌组织中的表达及其与淋巴血道转移和预后的关系。方法回顾分析56例术前未进行化疗和放疗的非小细胞肺癌的切除标本,采用免疫组化SP法检测肺癌组织中VEGF-C和CD44v6的表达,采用χ2检验分析其表达与肺癌生物学行为的关系,采用Kaplan-meier生存曲线及logrank方法检测生存率。结果鳞癌组织中VEGF-C、CD44v6的阳性表达率分别为65.63%(21/32)、56.25%(18/32),腺癌组织中分别为66.67%(16/24)、62.50%(15/24)。VEGF-C及CD44v6的阳性表达与肺癌淋巴结的转移、肺癌的病理分期关系密切(P<0.05),且与肺癌术后发生转移密切相关。VEGF-C、CD44v6阳性表达者3及5年生存率分别为18.79%、7.24%和17.73%、11.04%,阴性表达者为66.23%、59.55%和68.26%、54.33%,两者之间差异显著(P<0.05);VEGF-C与CD44v6阳性表达呈显著正相关。结论联合检测VEGF-C和CD44v6表达对于非小细胞肺癌淋巴血行转移、病理分期、术后转移复发的评估有一定临床意义,可用于指导临床选择正确的综合治疗。 Objective To investigate expressions of vascular endothelial growth factor C(VEGF-C) and CD44v6 in non-small cell lung cancer ( NSCLC) and to explore their association with invasion,metastasis and prognosis of NSCLC. Methods A rapid immunohistochemical method (streptavidin peroxidase,SP) was used to detect VEGF-C and CD44v6 protein expressions in 56 paraffin-embedded resected NSCLC tissues retrospectively. All the patients were initially treated. Results Expression rates of VEGF-C in squamous cell carcinoma and adenocarcinoma were 65. 63% (21/32) and 66. 67% (16/24) respectively. The positiv rates of CD44v6 expression in squamous cell carcinoma and adenocarcinoma were 56. 25% (18 /32) and 62. 50% (15 /24) respectively. The positive expressions of VEGF-C and CD44v6 were significantly correlated with lymph node metastasis and TNM stage (P〈0. 05),and also with post-operative hematogenous metastasis (P〈0. 05). The 3-and 5-year survival rates of patients with positive VEGF-C expression were 18. 79% and 7. 24% respectively,whereas they were 66. 23% and 59. 55% in those with negative expression,and there was a significant difference in the survival rate between the two groups (P〈0. 05). The 3-and 5-year survival rates were 17. 73% and 11. 04% in the CD44v6 positive expression group,and 68. 26% and 54. 33% in the negative expression group,and there was also a significant difference. VEGF-C had a correlation with the positive expression of CD44v6 (P〈0. 05). Conclusion Detection of VEGF-C and CD44v6 expressions in NSCLC is helpful to evaluate lymph node metastasis,TNM stage and prognosis. It is also helpful to guide post-operative multiple modality therapy.
出处 《山东大学学报(医学版)》 CAS 北大核心 2010年第4期83-86,共4页 Journal of Shandong University:Health Sciences
关键词 肺肿瘤 细胞粘附分子 免疫组织化学 肿瘤转移 血管内皮生长因子 Lung neoplasms Cell adhesion molecules Immunohistochemistry Neoplasm metastasis Vascular endothelial growth factor
  • 相关文献

参考文献10

  • 1Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice [ J ]. Science, 1997, 276(5317) :1423-1425.
  • 2Tamura M, Ohta Y. Serum vascular endothelial growth factor-C level in patients with primary non-small cell lung carcinoma: a possible diagnostic tool for lymph node metastasis[ J]. Cancer, 2003, 98(6) :1217-1222.
  • 3Kajita T, Ohta Y, Kimura K, et al. Expression of vascular endothelial growth factor- C and its receptors in non- small cell lung cancer[ J]. Br J Cancer, 2001, 85 (2) : 255 -260.
  • 4Arinago M, Noguchi T, Takeno S, et al. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma [ J ]. Cancer, 2003, 97 ( 2 ) : 457-464.
  • 5Kojima H, Shijubo N, Yamada G, et al. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma[ J ]. Cancer, 2005, 104 ( 8 ) : 1668- 1677.
  • 6Takenaka K, Yanagihara K, Kurozumi M, et al. Clinical significance of VEGF-C status in tumor cells and stromal macrophages in non-small cell lung cancer patients[ J ]. Br J Cancer, 2004, 91(3):498-503.
  • 7Wimmel A, Kogan E, Ramaswamy A, et al. Variant expression of CD44 in preneoplastic lesions of the lung[ J]. Cancer, 2001, 92 (5) : 1231-1236.
  • 8Toshiki H, Tatsuo F, Hironobu N, et al. Expression of CD44 variant exon 6 in stage Ⅰ non-small cell lung carcinoma as a prognostic factor[J]. Cancer Res, 1998, 58 (2) :1108-1110.
  • 9Miyoshi T, Kondo K, Hino N, et al. The expression of the CD44 valiant exon 6 is associated with lymph node metastasis in non-small cell lung cancer[ J ]. Clin Cancer Res, 1997, 3(8) :1289-1297.
  • 10Boming D, Masami S, Akira S, et al. Computed tomographic images reflect the biologic behavior of small lung adenocarcinoma: they correlate with cell proliferation, microvascularization, cell adhesion, degradation of extracellular matrix, and K-ras mutation[J]. Thorac Cardiovasc Surg, 2005, 130(7):733 -739.

同被引文献38

  • 1张凌,熊建萍,钟陆行.荧光定量PCR法检测转移性大肠癌患者化疗前后外周血CEAmRNA的表达及临床意义[J].实用肿瘤杂志,2006,21(5):443-446. 被引量:7
  • 2王卫军,杨林瀛,卢云涛,姜瑞华,高丽华,薛承岩.端粒酶、DNA异倍体和糖链抗原19-9与癌胚抗原诊断与鉴别诊断良、恶性胸腔积液价值的比较[J].临床荟萃,2007,22(4):282-284. 被引量:14
  • 3钱东华,左梦华,李丹,马忠森.CEA,CA199,CYFRA21-1测定对癌性、结核性胸腔积液的鉴别诊断价值[J].中国老年学杂志,2007,27(4):356-357. 被引量:8
  • 4Porcel J,VivesM,Esquerda A,et a.l Use of Panel of Markers in Pleural Fluid for Differential Diagnosis of Benign and Malignant Ef-fusions.Chest,2004,126:1757-1763.
  • 5Bustin SA,BenesV,NolanT,eta.l Quantitative real-time RT-PCR-a perspective[J].JMolEndocrinol,2005;34(3):597-601.
  • 6ShitritD,Zingerman B,ShitritAB,et a.l Diagnostic value of CYFRA21-1,CEA,CA 19-9,CA 15-3,and CA 125 assays in pleural efusions:analysis of116 cases and review of the literature.Oncologist,2005,10(7):501-507.
  • 7Lee JH,Chan g JH.Diagnostic utility ofserum and pleural fluid carcincembryonic antigen,neuron-specific enolase,and cyto-keratin 19 fragments in patientswith efusions from primary lung cancer.Chest,2005,128(4):2298-2303.
  • 8Ando S,Suzuki M,Yamamoto N,et al.The prognostic value of both neuronspecific enolase(NSE) and Cyfra21-1 in small cell lung cancer[J].Anticancer Res,2004,24(3B):1941~1946.
  • 9Pujol JL,Boher JM,Grenier J,et al.Neuron specitic enolase and prognosis of non-small cell lung cancer:prospective study in 621 patients[J].LungCancer,2001,31(2-3):221~228.
  • 10Natio T,Ohtuka M,Lshikawa H,et al.Clinical signifcance of cytokinemeasurement of pleural effusion[J] ·Kekkakku,1997,72(3):565~572.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部